UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19179) 19179
Dissertation (40) 40
Book Chapter (33) 33
Magazine Article (19) 19
Conference Proceeding (16) 16
Book / eBook (12) 12
Publication (9) 9
Web Resource (4) 4
Government Document (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13755) 13755
science & technology (12084) 12084
life sciences & biomedicine (11327) 11327
quinazolines - pharmacology (7711) 7711
female (6709) 6709
male (6288) 6288
quinazolines - therapeutic use (6008) 6008
animals (5964) 5964
oncology (5869) 5869
middle aged (4126) 4126
aged (3567) 3567
lung neoplasms - drug therapy (3469) 3469
quinazolines - administration & dosage (3270) 3270
adult (3061) 3061
receptor, epidermal growth factor - antagonists & inhibitors (3004) 3004
cell line, tumor (2868) 2868
mice (2844) 2844
antineoplastic agents - therapeutic use (2804) 2804
carcinoma, non-small-cell lung - drug therapy (2794) 2794
erlotinib hydrochloride (2684) 2684
pharmacology & pharmacy (2514) 2514
quinazolines - adverse effects (2333) 2333
antineoplastic agents - pharmacology (2284) 2284
gefitinib (2046) 2046
treatment outcome (1948) 1948
quinazolines - chemistry (1943) 1943
receptor, epidermal growth factor - genetics (1830) 1830
cancer (1809) 1809
mutation (1760) 1760
protein kinase inhibitors - therapeutic use (1734) 1734
receptor, epidermal growth factor - metabolism (1724) 1724
rats (1707) 1707
antineoplastic combined chemotherapy protocols - therapeutic use (1647) 1647
lung neoplasms - pathology (1620) 1620
protein kinase inhibitors - pharmacology (1596) 1596
quinazolines - chemical synthesis (1564) 1564
dose-response relationship, drug (1563) 1563
lung neoplasms - genetics (1478) 1478
epidermal growth factor (1457) 1457
quinazolines (1381) 1381
cell proliferation - drug effects (1372) 1372
chemistry (1354) 1354
aged, 80 and over (1325) 1325
biochemistry & molecular biology (1299) 1299
care and treatment (1184) 1184
analysis (1171) 1171
lung cancer (1166) 1166
erlotinib (1152) 1152
structure-activity relationship (1151) 1151
carcinoma, non-small-cell lung - pathology (1144) 1144
carcinoma, non-small-cell lung - genetics (1135) 1135
research (1132) 1132
physical sciences (1090) 1090
signal transduction - drug effects (1088) 1088
chemotherapy (1080) 1080
apoptosis - drug effects (1072) 1072
egfr (1055) 1055
breast neoplasms - drug therapy (1044) 1044
adenocarcinoma - drug therapy (984) 984
enzyme inhibitors - pharmacology (979) 979
cell biology (973) 973
phosphorylation (958) 958
lung cancer, non-small cell (953) 953
quinazolines - pharmacokinetics (948) 948
antineoplastic agents - adverse effects (943) 943
signal transduction (914) 914
disease-free survival (893) 893
tyrosine (877) 877
drug resistance, neoplasm (861) 861
breast cancer (854) 854
apoptosis (830) 830
time factors (829) 829
epidermal growth factor receptor (822) 822
molecular structure (822) 822
abridged index medicus (811) 811
kinases (798) 798
respiratory system (777) 777
mice, nude (771) 771
chemistry, medicinal (759) 759
quinazoline (752) 752
hematology, oncology and palliative medicine (743) 743
medicine & public health (735) 735
clinical trials as topic (734) 734
drug therapy (734) 734
neoplasm staging (732) 732
xenograft model antitumor assays (731) 731
antibodies, monoclonal, humanized (719) 719
prognosis (714) 714
tumors (680) 680
tumor cells, cultured (679) 679
tyrphostins - pharmacology (676) 676
antineoplastic agents - administration & dosage (671) 671
receptor, erbb-2 - metabolism (658) 658
quinazolines - metabolism (655) 655
neoplasms - drug therapy (653) 653
breast neoplasms - pathology (641) 641
protein-tyrosine kinases - antagonists & inhibitors (635) 635
cell survival - drug effects (632) 632
lung neoplasms - metabolism (628) 628
non-small cell lung cancer (628) 628
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18235) 18235
Japanese (500) 500
Chinese (328) 328
German (273) 273
French (190) 190
Spanish (82) 82
Italian (78) 78
Russian (68) 68
Hungarian (44) 44
Polish (31) 31
Portuguese (30) 30
Czech (27) 27
Ukrainian (16) 16
Danish (12) 12
Norwegian (9) 9
Dutch (6) 6
Finnish (4) 4
Korean (4) 4
Bulgarian (3) 3
Croatian (3) 3
Hebrew (3) 3
Arabic (2) 2
Romanian (2) 2
Swedish (2) 2
Turkish (2) 2
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Letters in drug design & discovery, ISSN 1570-1808, 2016, Volume 13, Issue 1, pp. 64 - 76
A series of 6,7-disubstituted-3-{2-[4-(substituted) piperazin-1-yl]-2-oxoethyl}quinazoline-2,4(1H, 3H)-dione derivatives (7-34) were synthesized and their... 
Cytotoxicity | Sulforhodamine B method | Quinazoline | Anticancer | Quinazoline-2,4(1H,3H)-dione | Piperazine | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 11/2009, Volume 27, Issue 33, pp. 5538 - 5546
Purpose Cross-talk between human epidermal growth factor receptors and hormone receptor pathways may cause endocrine resistance in breast cancer. This trial... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Triazoles - administration & dosage | Triazoles - adverse effects | Postmenopause - drug effects | Receptors, Estrogen - metabolism | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Receptors, Progesterone - genetics | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Dose-Response Relationship, Drug | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Invasiveness - pathology | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Carcinoma - pathology | Carcinoma - secondary | Carcinoma - drug therapy | Receptors, Estrogen - genetics | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Biomarkers, Tumor - analysis | Antineoplastic Agents, Hormonal - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Breast Neoplasms - pathology | Quinazolines - adverse effects | Survival Analysis | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Carcinoma - metabolism | Neoplasm Staging | Nitriles - adverse effects | Index Medicus | Carcinoma | Quinazolines | Breast Neoplasms | Life Sciences | Immunology | Triazoles | Postmenopause | Nitriles | Antineoplastic Agents, Hormonal | Tumor Markers, Biological | Receptors, Estrogen | Neoplasm Invasiveness | Antineoplastic Combined Chemotherapy Protocols | Receptor, erbB-2 | Receptors, Progesterone | Kaplan-Meiers Estimate
Journal Article
09/2009, An Interscience publication, ISBN 0471145653, 683
This supplement reflects and emphasizes research trends. Due to the vast increase in the number and types of individualized quinazolines described in... 
Quinazoline
eBook
Journal of clinical oncology, ISSN 1527-7755, 09/2013, Volume 31, Issue 27, pp. 3327 - 3334
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2009, Volume 27, Issue 8, pp. 1268 - 74
Journal Article
Cell (Cambridge), ISSN 0092-8674, 01/2018, Volume 172, Issue 3, pp. 578 - 589.e17
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 04/2012, Volume 30, Issue 10, pp. 1122 - 1128
Journal Article
Journal Article
Journal Article